NewswireToday - /newswire/ -
Sebastian, FL, United States, 2008/03/07 - An editorial series on how US drug supply network questions where counterfeit drug liability lies has been written by Alan Clock, a 20-year veteran in the pharmaceutical industry.
A four part opinion series of articles on supply chain liability within the pharmaceutical industry is now available to the public. The write-up covers how each segment of the US drug supply network questions where counterfeit drug liability lies.
Alan Clock, a 20 year veteran of the pharmaceutical industry, authored the series. “Nobody wants to be responsible for a passing on, ultimately to the consumer, counterfeit or fake medications,” Clock said. “The current reality is that every member of the pharmaceutical supply chain should be responsible and do everything possible to protect the public. Those members who haven’t adopted or embraced new technologies to authenticate or protect their inventories will appear as the weak link and be very vulnerable to those with a nefarious intent and liability.”
The final installment of the series covers a new piece of equipment which is being offered as a solution to mitigate risk within the pharmaceutical industry. The XT250 Authentication System from XStream Systems, Inc. verifies pharmaceuticals at a crystalline level and while in their original sealed packaging. The equipment can assist manufacturers, distributors, wholesalers, and dispensers when having to defend themselves over products which left their facilities.
The series can be viewed at SecurePharmaChain's Blog.
About XStream Systems, Inc.
XStream Systems (xstreamsystems.net) produces next-generation equipment for material identification. Their patented systems are based on Energy-Dispersive X-Ray Diffraction (EDXRD) technology. The company’s XT250™ System enables testing of powders, pills AND entire sealed bottles. The equipment’s superior sample penetration allows the identification of contents inside opaque plastic, cardboard and even metal packaging.